J&J suspends sales forecast for COVID vaccine - Reuters

10:38am PDT - April 19th, 2022    johnson and johnson vaccine - Reuters

Johnson & Johnson on Tuesday cut its full-year profit expectation and suspended sales forecast for its COVID-19 vaccine after having earlier predicted as much as $3.5 billion in sales from the shot. This report produced by Chris Dignam.